Header Logo

MEGHANA TRIVEDI

Concepts (280)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with MEGHANA TRIVEDI's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that MEGHANA TRIVEDI has written about over time.
Receptors, Dopamine D1, 3 publications between 2004 and 2005, average publication date August 2004. Granulocyte Colony-Stimulating Factor, 3 publications between 2009 and 2015, average publication date August 2011. Prescription Drugs, 2 publications between 2010 and 2019, average publication date November 2014. Estrogen Antagonists, 2 publications between 2011 and 2018, average publication date May 2015. Receptors, Estrogen, 8 publications between 2011 and 2020, average publication date May 2016. Neoplastic Cells, Circulating, 4 publications between 2013 and 2019, average publication date July 2016. Receptors, G-Protein-Coupled, 4 publications between 2005 and 2022, average publication date October 2016. Antineoplastic Agents, Hormonal, 7 publications between 2011 and 2022, average publication date February 2017. Breast Neoplasms, 29 publications between 2008 and 2023, average publication date April 2017. Drug Resistance, Neoplasm, 9 publications between 2011 and 2022, average publication date May 2017. Quinolines, 1 publications between 2019 and 2019, average publication date January 2019. Class I Phosphatidylinositol 3-Kinases, 1 publications between 2019 and 2019, average publication date March 2019. Single-Cell Analysis, 1 publications between 2019 and 2019, average publication date March 2019. Estrogen Receptor alpha, 2 publications between 2016 and 2022, average publication date June 2019. Receptor, ErbB-2, 9 publications between 2013 and 2023, average publication date June 2019. Oncogene Proteins, 2 publications between 2018 and 2021, average publication date November 2019. Medication Adherence, 4 publications between 2018 and 2023, average publication date March 2020. Breast Neoplasms, Male, 1 publications between 2020 and 2020, average publication date June 2020. Endocrine Gland Neoplasms, 1 publications between 2022 and 2022, average publication date February 2022. Receptors, Neuropeptide Y, 1 publications between 2022 and 2022, average publication date February 2022.

To see the data from this visualization as text, click here.
TRIVEDI's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (280)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_